{"result": {"id": "d9a01dd0-4c14-4036-a581-624840b93ce3", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Resistant Hypertension and Related Conditions\",\n    \"summary\": \"The community centers around Resistant Hypertension, a severe form of high blood pressure resistant to conventional treatments, and its related conditions such as Obstructive Sleep Apnea Syndrome (OSAS), Obesity, and Primary Aldosteronism. These entities are interconnected through various relationships, highlighting the complexity of managing resistant hypertension and its comorbidities. The community includes a range of diagnostic tests, treatments, and research efforts aimed at addressing these conditions.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant health risks associated with resistant hypertension and its related conditions, which require specialized treatments and can lead to severe complications if not properly managed.\",\n    \"findings\": [\n        {\n            \"summary\": \"Resistant Hypertension as a central condition\",\n            \"explanation\": \"Resistant Hypertension is the central entity in this community, defined as high blood pressure that remains uncontrolled despite treatment with three or more antihypertensive medications. This condition poses significant health risks and requires specialized treatment approaches, including the use of drugs like aprocitentan. [Data: Entities (951), Relationships (798, 1820, 1821, 1824)]\"\n        },\n        {\n            \"summary\": \"Role of OSAS in the community\",\n            \"explanation\": \"Obstructive Sleep Apnea Syndrome (OSAS) is a key related condition, strongly linked to nighttime hypertension and contributing to the complexity of managing resistant hypertension. Treatments for OSAS, such as CPAP and MAD, are important in the overall management strategy. [Data: Entities (1473, 1621), Relationships (1469, 1896, 1898)]\"\n        },\n        {\n            \"summary\": \"Obesity's impact on hypertension\",\n            \"explanation\": \"Obesity is a significant risk factor for both resistant hypertension and childhood hypertension, highlighting its role in the community. It is also frequently comorbid with other conditions like type 2 diabetes, further complicating treatment strategies. [Data: Entities (1497), Relationships (1726, 1523)]\"\n        },\n        {\n            \"summary\": \"Primary Aldosteronism and its diagnostic challenges\",\n            \"explanation\": \"Primary Aldosteronism is another key condition within the community, characterized by excessive aldosterone production leading to hypertension and hypokalemia. Its diagnosis involves specific tests like the aldosterone-to-renin ratio (ARR) and saline infusion test, underscoring the need for specialized diagnostic approaches. [Data: Entities (1290), Relationships (1828, 1829, 1966, 1967)]\"\n        },\n        {\n            \"summary\": \"Treatment options for resistant hypertension\",\n            \"explanation\": \"The community includes various treatment options for resistant hypertension, such as renal denervation (RDN) and the use of mineralocorticoid receptor antagonists (MRA). These treatments highlight the ongoing efforts to manage this challenging condition. [Data: Entities (1619, 1733), Relationships (1820, 1973)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751560525, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 649, "prompt_tokens": 7049, "total_tokens": 7698, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1600}, "prompt_cache_hit_tokens": 1600, "prompt_cache_miss_tokens": 5449}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n951,RESISTANT HYPERTENSION,\"**Resistant Hypertension** is a severe form of hypertension characterized by persistently high blood pressure that remains uncontrolled despite treatment with three or more antihypertensive medications, including a diuretic. It is defined as blood pressure that stays above the target goal even when a patient is on a concurrent regimen of three antihypertensive agents. In cases where standard therapies fail, treatments such as **aprocitentan** may be considered. This condition represents a challenging clinical scenario due to its resistance to conventional management strategies.  \n\nThe descriptions consistently emphasize that resistant hypertension involves the failure of multiple drug therapies to achieve blood pressure control, reinforcing its definition as a difficult-to-treat form of high blood pressure.\",10\n1473,OSAS,\"Obstructive sleep apnea syndrome, a clinical condition associated with nighttime hypertension\nObstructive Sleep Apnea Syndrome, a sleep disorder strongly linked to nighttime hypertension\",15\n1497,OBESITY,\"**Obesity** is a medical condition characterized by excessive or excess body fat. It is frequently comorbid with hypertension, diabetes, and metabolic syndrome, highlighting its association with multiple serious health conditions. Additionally, obesity is recognized as the leading risk factor for childhood hypertension, independently contributing nearly 20% to the risk. This underscores its significant impact on both pediatric and adult populations, linking it to a range of metabolic and cardiovascular complications.  \n\n*(Note: Contradictions were resolved by combining overlapping details—e.g., \"\"hypertension and diabetes\"\" and \"\"hypertension and metabolic syndrome\"\" were merged into a broader list of comorbidities.)*\",6\n1623,RENAL ARTERY STENOSIS,\"Narrowing of renal arteries, a potential cause of refractory hypertension\"\"\",5\n1290,PRIMARY ALDOSTERONISM,,18\n1621,SLEEP APNEA SYNDROME,Sleep apnea syndrome is another potential cause of secondary hypertension that needs screening in resistant hypertension cases,5\n1731,HYPOKALEMIA,\"Hypokalemia is low potassium levels in the blood, commonly seen in primary aldosteronism due to excessive aldosterone secretion.\"\"\",2\n1734,ADRENAL INCIDENTALOMA,,2\n3721,MONTICONE S,\"Monticone S is a researcher involved in multiple studies on primary aldosteronism, including its prevalence, clinical manifestations, and cardiovascular risks>\",2\n1682,ADRENAL CORTEX,The adrenal cortex is the outer part of the adrenal gland that produces hormones like aldosterone>,1\n1727,ALDOSTERONE-TO-RENIN RATIO (ARR),\"The aldosterone-to-renin ratio (ARR) is a screening test for primary aldosteronism. It involves measuring aldosterone and renin levels, with specific cutoff values indicating the need for further confirmatory testing.\"\"\",1\n1728,SALINE INFUSION TEST,\"The saline infusion test is a confirmatory test for primary aldosteronism, where saline is administered intravenously to suppress aldosterone levels in normal individuals, but not in those with primary aldosteronism.\"\"\",1\n1729,CAPTOPRIL TEST,\"The captopril test is a confirmatory test for primary aldosteronism, where captopril is administered to observe the suppression of aldosterone levels in normal individuals, but not in those with primary aldosteronism.\"\"\",1\n1730,FLUDROCORTISONE SUPPRESSION TEST,\"The fludrocortisone suppression test is a confirmatory test for primary aldosteronism, but it is rarely used in some regions due to the unavailability of the drug.\"\"\",1\n1732,RENIN-ANGIOTENSIN SYSTEM (RAS),\"The renin-angiotensin system regulates blood pressure and fluid balance, and its suppression is a key feature in primary aldosteronism.\"\"\",1\n1733,MINERALOCORTICOID RECEPTOR ANTAGONISTS (MRA),\"Mineralocorticoid receptor antagonists are drugs used in the management of primary aldosteronism to block aldosterone effects.\"\"\",1\n1762,ADRENAL ABLATION,\"A treatment method for primary aldosteronism when medications are ineffective or surgery is unsuitable\"\"\",1\n1668,APAP,\"Automatic Positive Airway Pressure (APAP) is a type of PAP therapy that adjusts air pressure dynamically based on the patient's breathing patterns.\"\"\",2\n1652,DIABETES MELLITUS TYPE 2,A comorbidity frequently associated with OSAS,1\n1653,PULMONARY HYPERTENSION,A condition that may be associated with OSAS,1\n1670,MAD,\"Mandibular Advancement Device (MAD) is an oral appliance used to treat mild to moderate OSAS by advancing the lower jaw to keep the airway open.\"\"\",1\n1671,ASV,\"Adaptive Servo-Ventilation (ASV) is a type of PAP therapy that adjusts pressure support based on the patient's breathing patterns, often used for complex sleep apnea.\"\"\",1\n1678,BLOCKED SLEEP APNEA SYNDROME,,1\n1667,PAP,\"Positive Airway Pressure (PAP) therapy is a treatment for OSAS that includes CPAP, APAP, and BiPAP. It is recommended for moderate to severe OSAS patients, especially those with daytime sleepiness or comorbid conditions like hypertension.\"\"\",4\n1625,CPAP,\"**Continuous Positive Airway Pressure (CPAP)** is a type of positive airway pressure (PAP) therapy primarily used to treat **Obstructive Sleep Apnea Syndrome (OSAS)** and other forms of **sleep apnea**. It works by delivering a constant and steady stream of air through a mask, which helps keep the patient's airways open during sleep, preventing interruptions in breathing. CPAP is a widely recognized and effective treatment for sleep-related breathing disorders, improving sleep quality and overall health for individuals affected by these conditions.\",10\n919,STANDARD CUFF,A blood pressure measurement accessory with size specifications based on arm circumference,3\n924,BLOOD PRESSURE MEASUREMENT,,10\n917,ELECTRONIC BLOOD PRESSURE MONITOR,\"A recommended device for blood pressure measurement, validated for accuracy\",2\n918,MERCURY SPHYGMOMANOMETER,\"A deprecated device for blood pressure measurement, no longer recommended for use\",2\n920,LARGE CUFF,A blood pressure measurement accessory for patients with arm circumference >32 cm,2\n921,SMALL CUFF,A blood pressure measurement accessory for patients with arm circumference <24 cm,2\n1496,CHILDREN HYPERTENSION,\"A health condition affecting children under 18, with primary and secondary types, influenced by factors like obesity, family history, and lifestyle\"\"\",6\n1666,PAP THERAPY,\"Positive Airway Pressure therapy, including CPAP and automatic PAP, for treating OSAS\"\"\",2\n916,UPPER ARM BLOOD PRESSURE,\"The standard measurement location for blood pressure assessment, with specific positioning requirements\",1\n922,STANDING BLOOD PRESSURE,An additional blood pressure measurement for specific patient groups like elderly or diabetics,1\n923,PULSE RATE MEASUREMENT,A concurrent measurement taken during blood pressure assessment,1\n1619,RDN TREATMENT,RDN treatment is a potential therapy for resistant hypertension when other treatments fail,1\n1620,REFRACTORY HYPERTENSION,\"Refractory hypertension is diagnosed when blood pressure remains uncontrolled despite the use of five or more antihypertensive medications, including a diuretic and an aldosterone receptor antagonist\",1\n1622,BLOOD PRESSURE REGISTRY STUDY,A nationwide study conducted from 2009-2013 across 59 hospitals in 18 provinces that found resistant hypertension prevalence was 8.3% in China,1\n1626,RDN,\"Renal denervation, a device-based treatment for hypertension\"\"\",1\n1665,UPPP,\"Uvulopalatopharyngoplasty, a surgical procedure for treating OSAS in select patients\"\"\",1\n1680,AUTOCPAP,\"Automatic Continuous Positive Airway Pressure, an adaptive form of CPAP therapy>\",1\n1323,SECONDARY HYPERTENSION,\"**SECONDARY HYPERTENSION** is a form of hypertension caused by an identifiable underlying condition, such as kidney diseases, and requires thorough evaluation to exclude before considering treatments like renal denervation (RDN). It is more prevalent in younger children compared to adults, often linked to specific underlying health issues. Secondary hypertension accounts for approximately 11%-14% of chronic hypertension cases, distinguishing it from primary (essential) hypertension. Due to its identifiable causes, it necessitates additional diagnostic workup to address the root condition effectively.\",6\n1627,RENAL PARENCHYMAL HYPERTENSION,\"Hypertension caused by kidney disease\"\"\",3\n1499,PRIMARY HYPERTENSION,\"Hypertension in children without an identifiable secondary cause, increasing with age\"\"\",2\n1498,KIDNEY DISEASES,\"The primary cause of secondary hypertension in children, accounting for over 40% of cases\"\"\",2\n1636,FIBROMUSCULAR DYSPLASIA (FMD),\"Fibromuscular Dysplasia (FMD) is a vascular condition that can cause renal artery stenosis, leading to secondary hypertension. It accounts for a small percentage of renal artery stenosis cases, with atherosclerosis being the more common cause.\"\"\",1\n1637,RENOVASCULAR HYPERTENSION,\"Renovascular hypertension is a form of secondary hypertension resulting from reduced kidney blood flow, often due to renal artery stenosis. It accounts for 3-5% of hypertension cases and can be caused by atherosclerosis, FMD, or other vascular abnormalities.\"\"\",7\n1639,NUTCRACKER SYNDROME,\"Nutcracker syndrome is a vascular compression condition that may lead to hematuria and proteinuria, with potential to cause secondary hypertension in later stages.\"\"\",1\n1640,MALIGNANT HYPERTENSION,\"Malignant hypertension is a severe form of high blood pressure that can be associated with renal artery stenosis and requires urgent medical intervention.\"\"\",1\n1641,HYPERTENSION WITH HYPOKALEMIA,\"Hypertension with hypokalemia is a clinical clue suggesting possible secondary hypertension due to renal artery stenosis or other endocrine causes.\"\"\",1\n1495,2019 NATIONAL STUDENT PHYSIQUE SURVEY,\"A 2019 survey that showed a 13.0% hypertension prevalence among children aged 6-17, with higher rates in rural areas and varying by region\"\"\",1\n1628,RENAL DENERVATION,,1\n1624,THYROID DISORDERS,\"Thyroid dysfunction can contribute to refractory hypertension\"\"\",1\n1638,LARGE ARTERY VASCULITIS,\"Large artery vasculitis (including conditions like Takayasu arteritis) accounts for 12% of renal artery stenosis cases in China, contributing to renovascular hypertension.\"\"\",1\n1642,ARTERIOSCLEROSIS,,1\n3713,WORKING GROUP ON ENDOCRINE HYPERTENSION OF THE EUROPEAN SOCIETY OF HYPERTENSION,The Working Group on Endocrine Hypertension of The European Society of Hypertension published a position statement and consensus on primary aldosteronism>,3\n3752,MULATERO P,\"**MULATERO P** is a researcher specializing in the study of genetics, prevalence, screening, and confirmation of primary aldosteronism. They have contributed to the field by co-authoring consensus statements on primary aldosteronism, demonstrating their expertise and involvement in advancing understanding and guidelines related to this condition. Their work highlights a focus on both the scientific and clinical aspects of primary aldosteronism research.\",2\n1659,POLYSOMNOGRAPHY,\"The gold standard diagnostic test for obstructive sleep apnea syndrome (OSAS)\"\"\",3\n1660,PORTABLE SLEEP RESPIRATORY MONITOR,\"A device used for diagnosing OSAS, an alternative to polysomnography\"\"\",1\n1661,AHI,\"Apnea-Hypopnea Index, used to diagnose and classify the severity of OSAS\"\"\",1\n1663,AUTOMATIC POSITIVE AIRWAY PRESSURE,\"A type of PAP therapy for treating OSAS\"\"\",2\n1669,BIPAP,\"Bilevel Positive Airway Pressure (BiPAP) is a type of PAP therapy that provides two levels of air pressure: higher during inhalation and lower during exhalation.\"\"\",3\n1681,AUTOBIPAP,\"Automatic Bilevel Positive Airway Pressure, an adaptive form of BiPAP therapy>\",1\n3753,DEINUM J,Deinum J is a researcher involved in position statements on primary aldosteronism>,1\n1287,APROCITENTAN,\"Aprocitentan is the only approved dual endothelin receptor antagonist for resistant hypertension. It inhibits ET-1 binding to ETA and ETB receptors, reducing blood pressure and vascular permeability. It has a long half-life, allowing once-daily dosing.\",2\n1288,ET-1,\"Endothelin-1 (ET-1) is a peptide that binds to ETA and ETB receptors, influencing vascular tone and permeability. Its inhibition by aprocitentan helps lower blood pressure.\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n798,RESISTANT HYPERTENSION,HIGH BLOOD PRESSURE,Resistant hypertension is a severe form of high blood pressure that requires special treatment approaches,40\n1469,OSAS,ISH,\"OSAS is a contributing factor to both nighttime hypertension and ISH in many patients\nOSAS is a condition that can contribute to nighttime hypertension, which is related to ISH\",28\n1726,OBESITY,DIABETES,Obesity significantly increases the risk of developing type 2 diabetes,27\n1828,RENAL ARTERY STENOSIS,PRIMARY ALDOSTERONISM,Both are organic causes of refractory hypertension requiring specific diagnosis,23\n1829,SLEEP APNEA SYNDROME,PRIMARY ALDOSTERONISM,Both are common secondary causes of refractory hypertension,23\n1970,PRIMARY ALDOSTERONISM,HYPOKALEMIA,Excessive aldosterone in primary aldosteronism leads to hypokalemia.,20\n1971,PRIMARY ALDOSTERONISM,ADRENAL INCIDENTALOMA,\"Adrenal incidentalomas may secrete aldosterone, causing primary aldosteronism.\",20\n3750,MONTICONE S,PRIMARY ALDOSTERONISM,Monticone S conducted multiple studies on primary aldosteronism,20\n1913,PRIMARY ALDOSTERONISM,ADRENAL CORTEX,The adrenal cortex overproduces aldosterone in primary aldosteronism,19\n1966,PRIMARY ALDOSTERONISM,ALDOSTERONE-TO-RENIN RATIO (ARR),The aldosterone-to-renin ratio (ARR) is used as a screening tool for primary aldosteronism.,19\n1967,PRIMARY ALDOSTERONISM,SALINE INFUSION TEST,The saline infusion test is one of the confirmatory tests for primary aldosteronism.,19\n1968,PRIMARY ALDOSTERONISM,CAPTOPRIL TEST,The captopril test is one of the confirmatory tests for primary aldosteronism.,19\n1969,PRIMARY ALDOSTERONISM,FLUDROCORTISONE SUPPRESSION TEST,\"The fludrocortisone suppression test is a confirmatory test for primary aldosteronism, though rarely used in some regions.\",19\n1972,PRIMARY ALDOSTERONISM,RENIN-ANGIOTENSIN SYSTEM (RAS),Primary aldosteronism suppresses the renin-angiotensin system due to autonomous aldosterone production.,19\n1973,PRIMARY ALDOSTERONISM,MINERALOCORTICOID RECEPTOR ANTAGONISTS (MRA),MRAs are used to treat primary aldosteronism by blocking aldosterone's effects.,19\n2013,ADRENAL ABLATION,PRIMARY ALDOSTERONISM,Adrenal ablation is an alternative treatment for primary aldosteronism,19\n1896,OSAS,APAP,APAP is a specific type of PAP therapy used to treat OSAS.,17\n1871,OSAS,DIABETES MELLITUS TYPE 2,OSAS is frequently comorbid with type 2 diabetes due to shared metabolic dysregulation,16\n1872,OSAS,PULMONARY HYPERTENSION,OSAS can contribute to the development of pulmonary hypertension,16\n1898,OSAS,MAD,\"**OSAS (Obstructive Sleep Apnea Syndrome)** is a sleep disorder characterized by repeated episodes of upper airway obstruction during sleep. **MAD (Mandibular Advancement Device)** is a treatment option for mild to moderate cases of OSAS. It serves as an alternative therapy, particularly for patients who are unable to tolerate PAP (Positive Airway Pressure) therapy. MAD works by repositioning the lower jaw forward to help maintain an open airway during sleep, making it a viable non-invasive option for managing mild to moderate OSAS symptoms.  \n\nIn summary, MAD is recommended for mild to moderate OSAS or as an alternative when PAP therapy is not suitable for the patient.\",16\n1899,OSAS,ASV,\"ASV is a specialized PAP therapy used for complex sleep apnea, including certain cases of OSAS.\",16\n1900,OSAS,BLOCKED SLEEP APNEA SYNDROME,Alternative names referring to the same medical condition,16\n1901,PAP,CPAP,CPAP is a subtype of PAP therapy.,14\n756,STANDARD CUFF,BLOOD PRESSURE MEASUREMENT,Standard cuffs are used for normal arm circumference measurements,13\n753,ELECTRONIC BLOOD PRESSURE MONITOR,BLOOD PRESSURE MEASUREMENT,Electronic monitors are the recommended device for blood pressure measurement,12\n755,MERCURY SPHYGMOMANOMETER,BLOOD PRESSURE MEASUREMENT,Mercury sphygmomanometers are no longer recommended for blood pressure measurement,12\n759,LARGE CUFF,BLOOD PRESSURE MEASUREMENT,Large cuffs are used for patients with larger arm circumference,12\n760,SMALL CUFF,BLOOD PRESSURE MEASUREMENT,Small cuffs are used for patients with smaller arm circumference,12\n1523,CHILDREN HYPERTENSION,OBESITY,Obesity is the leading risk factor for childhood hypertension,12\n1892,CPAP,PAP THERAPY,CPAP is a type of PAP therapy,12\n752,UPPER ARM BLOOD PRESSURE,BLOOD PRESSURE MEASUREMENT,Upper arm is the standard measurement location for blood pressure assessment,11\n761,STANDING BLOOD PRESSURE,BLOOD PRESSURE MEASUREMENT,Standing measurements are required for specific patient groups,11\n762,PULSE RATE MEASUREMENT,BLOOD PRESSURE MEASUREMENT,Pulse rate is measured concurrently with blood pressure,11\n1820,RDN TREATMENT,RESISTANT HYPERTENSION,RDN treatment is considered for patients with resistant hypertension when other treatments fail,11\n1821,RESISTANT HYPERTENSION,REFRACTORY HYPERTENSION,Refractory hypertension is a more severe form of resistant hypertension,11\n1824,RESISTANT HYPERTENSION,BLOOD PRESSURE REGISTRY STUDY,The study measured the prevalence and characteristics of resistant hypertension in China,11\n1833,CPAP,RDN,Both are treatments for conditions related to hypertension (sleep apnea and resistant hypertension),11\n1891,CPAP,UPPP,\"Both are treatment options for OSAS, with UPPP being surgical and CPAP being non-invasive\",11\n1911,CPAP,AUTOCPAP,autoCPAP is an advanced version of CPAP with automatic pressure adjustment,11\n1835,SECONDARY HYPERTENSION,RENAL PARENCHYMAL HYPERTENSION,Renal parenchymal hypertension is a type of secondary hypertension,9\n1525,CHILDREN HYPERTENSION,PRIMARY HYPERTENSION,Primary hypertension is a type of childhood hypertension,8\n1528,KIDNEY DISEASES,SECONDARY HYPERTENSION,Kidney diseases are the primary cause of secondary hypertension in children,8\n1560,SECONDARY HYPERTENSION,PRIMARY HYPERTENSION,Primary and secondary hypertension are the two main classifications of chronic hypertension,8\n1851,FIBROMUSCULAR DYSPLASIA (FMD),RENOVASCULAR HYPERTENSION,FMD is a cause of renovascular hypertension due to renal artery stenosis.,8\n1854,RENOVASCULAR HYPERTENSION,NUTCRACKER SYNDROME,Nutcracker syndrome may potentially contribute to renovascular hypertension in advanced cases.,8\n1856,RENOVASCULAR HYPERTENSION,MALIGNANT HYPERTENSION,Malignant hypertension can be a severe manifestation of renovascular hypertension.,8\n1857,RENOVASCULAR HYPERTENSION,HYPERTENSION WITH HYPOKALEMIA,Hypertension with hypokalemia is a clinical indicator of possible renovascular hypertension.,8\n1522,2019 NATIONAL STUDENT PHYSIQUE SURVEY,CHILDREN HYPERTENSION,\"The survey provided key prevalence data about childhood hypertension\nThe survey provided data on the prevalence of hypertension among children\",7\n1836,SECONDARY HYPERTENSION,RENAL DENERVATION,Renal denervation may be used for certain cases of secondary hypertension,7\n1830,SLEEP APNEA SYNDROME,THYROID DISORDERS,Both conditions may coexist and contribute to blood pressure elevation,6\n1858,LARGE ARTERY VASCULITIS,RENAL ARTERY STENOSIS,Large artery vasculitis accounts for 12% of renal artery stenosis cases in China.,6\n1859,RENAL ARTERY STENOSIS,ARTERIOSCLEROSIS,Arteriosclerosis is the predominant cause (82%) of renal artery stenosis in China.,6\n3747,WORKING GROUP ON ENDOCRINE HYPERTENSION OF THE EUROPEAN SOCIETY OF HYPERTENSION,MONTICONE S,Monticone S contributed to a consensus statement published by the Working Group on Endocrine Hypertension,5\n3748,WORKING GROUP ON ENDOCRINE HYPERTENSION OF THE EUROPEAN SOCIETY OF HYPERTENSION,MULATERO P,Mulatero P co-authored a consensus statement for the Working Group,5\n1886,POLYSOMNOGRAPHY,PORTABLE SLEEP RESPIRATORY MONITOR,Both are used for diagnosing sleep apnea,4\n1887,POLYSOMNOGRAPHY,AHI,AHI is measured during polysomnography to diagnose OSAS,4\n1893,AUTOMATIC POSITIVE AIRWAY PRESSURE,PAP THERAPY,Automatic PAP is a type of PAP therapy,4\n1912,BIPAP,AUTOBIPAP,autoBiPAP is an advanced version of BiPAP with automatic pressure adjustment,4\n3749,WORKING GROUP ON ENDOCRINE HYPERTENSION OF THE EUROPEAN SOCIETY OF HYPERTENSION,DEINUM J,Deinum J contributed to the Working Group's position statement,4\n1191,APROCITENTAN,ET-1,\"Aprocitentan inhibits ET-1 binding to its receptors, reducing blood pressure.\",3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_3ff6148491665fb09fcf07a4293d6d868a84349e77672af62ed228cd3c90ef56_v2"}